Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Conditions
Recurrent Solid Tumor · Recurrent Ewing Sarcoma · Recurrent Hepatoblastoma · Recurrent Malignant Germ Cell Tumor · Recurrent Malignant Solid Neoplasm · Recurrent Neuroblastoma · Recurrent Osteosarcoma · Recurrent Peripheral Primitive Neuroectodermal Tumor · Recurrent Rhabdoid Tumor · Recurrent Rhabdomyosarcoma · Recurrent Soft Tissue Sarcoma · Recurrent Wilms Tumor · Refractory Ewing Sarcoma · Refractory Hepatoblastoma · Refractory Malignant Germ Cell Tumor · Refractory Malignant Solid Neoplasm · Refractory Neuroblastoma · Refractory Osteosarcoma · Refractory Peripheral Primitive Neuroectodermal Tumor · Refractory Rhabdoid Tumor · Refractory Rhabdomyosarcoma · Refractory Soft Tissue Sarcoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
- Lucille Packard Children's Hospital Stanford, Palo Alto, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, Georgia, United States
- Children's Hospital and Clinics of Minn, Minneapolis, Minnesota, United States
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
- Texas Children's Hospital/ Baylor College of Medicine, Houston, Texas, United States
- The Hospital for Sick Children, Toronto, Ontario, Canada
- CHU Sainte-Justine, Montreal, Canada
- BC Children's Hospital Research Institute, Vancouver, Canada